The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units

Annals of Internal Medicine

Volumn 135, Issue 3, 2001, Pages 175-183

  Fridkin, S K ^a   Edwards, J R ^a   Courval, J M ^a   Hill, H ^a   Tenover, F C ^a   Lawton, R ^a   Gaynes, R P ^a   McGowan J E , Jr ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATION; DRUG USE; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035822694     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-3-200108070-00009     Document Type: Article

References (29)

1. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
2. Bloodstream infections with vancomycin-resistant enterococci
3. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
4. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993
5. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
6. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center
7. Risk factors for mortality associated with enterococcal bloodstream infections
8. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
9. Recommendations for preventing the spread of vancomycin resistance
10. Improving clinician adherence to vancomycin-use guidelines: Results of a pharmacist-based strategy at an academic medical center
11. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines
12. Vancomycin utilization project based on the HICPAC guidelines in thirteen Northeastern States
13. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention
14. Vancomycin use in a university medical center: Comparison with hospital infection control practices advisory committee guidelines
15. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci
16. Vancomycin control measures at a tertiary-care hospital: Impact of interventions on volume and patterns of use
17. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci
18. CDC definitions for nosocomial infections, 1988
19. National nosocomial infections surveillance system (NNIS): Description of surveillance methods
20. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
21. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of project ICARE laboratories
22. APACHE II: A severity of disease classification system
23. Objective, quantitative measurement of severity of illness in critically ill patients
24. Ecologic studies in epidemiology: Concepts, principles, and methods
25. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections
26. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership
27. Controlling use of antimicrobial agents
28. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals
29. Managing antibiotic use - Impact of infection control